Cargando…
Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada
PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prio...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303606/ https://www.ncbi.nlm.nih.gov/pubmed/32775788 http://dx.doi.org/10.1016/j.adro.2020.06.002 |
_version_ | 1783548094553522176 |
---|---|
author | Koch, Christine A. Lee, Grace Liu, Zhihui A. Liu, Fei-Fei Fyles, Anthony Han, Kathy Barry, Aisling Croke, Jennifer Rodin, Danielle Helou, Joelle Hahn, Ezra Isfahanian, Naghmeh DeRocchis, Jane Lofgren, Susanne Purdie, Thomas G. |
author_facet | Koch, Christine A. Lee, Grace Liu, Zhihui A. Liu, Fei-Fei Fyles, Anthony Han, Kathy Barry, Aisling Croke, Jennifer Rodin, Danielle Helou, Joelle Hahn, Ezra Isfahanian, Naghmeh DeRocchis, Jane Lofgren, Susanne Purdie, Thomas G. |
author_sort | Koch, Christine A. |
collection | PubMed |
description | PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiation therapy by oncologic risk and omission or deferral of radiation therapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers and preserves resources. Herein, we present our early response and adaptation of breast radiation therapy utilization during the COVID-19 pandemic at a large academic cancer center in Canada. METHODS AND MATERIALS: A state of emergency was announced in Ontario on March 17, 2020, owing to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast radiation therapy starts, type of breast radiation therapy, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: After the declaration of emergency in Ontario, there was a decrease of 39% in radiation therapy starts in 2020 compared with 2019 (79 vs 129, P < .001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared with 2019 (46% vs 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiation therapy were aged >50 years in 2020, 66% (78 of 118) versus 83% (132 of 160) in 2019, P = .0027. CONCLUSIONS: A significant reduction in breast radiation therapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiation therapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical and is of particular importance for higher volume cancer sites where the potential effect on resources is greater. |
format | Online Article Text |
id | pubmed-7303606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73036062020-06-19 Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada Koch, Christine A. Lee, Grace Liu, Zhihui A. Liu, Fei-Fei Fyles, Anthony Han, Kathy Barry, Aisling Croke, Jennifer Rodin, Danielle Helou, Joelle Hahn, Ezra Isfahanian, Naghmeh DeRocchis, Jane Lofgren, Susanne Purdie, Thomas G. Adv Radiat Oncol Practical considerations during COVID19 – Outcomes, education, and intervention PURPOSE: Mitigation strategies to balance the risk of coronavirus disease 2019 (COVID-19) infection against oncologic risk in patients with breast cancer undergoing radiation therapy have been deployed. To this end, shorter hypofractionated regimens have been recommended where appropriate, with prioritization of radiation therapy by oncologic risk and omission or deferral of radiation therapy for lower risk cases. Timely adoption of these measures reduces COVID-19 risk to both patients and health care workers and preserves resources. Herein, we present our early response and adaptation of breast radiation therapy utilization during the COVID-19 pandemic at a large academic cancer center in Canada. METHODS AND MATERIALS: A state of emergency was announced in Ontario on March 17, 2020, owing to the COVID-19 pandemic. Emergency guidelines were instituted. To examine our response, the number of weekly breast radiation therapy starts, type of breast radiation therapy, and patient age were compared from March 1 to April 30, 2020 to the same period in 2019. RESULTS: After the declaration of emergency in Ontario, there was a decrease of 39% in radiation therapy starts in 2020 compared with 2019 (79 vs 129, P < .001). There was a relative increase in the proportion of patients receiving regional nodal irradiation (RNI) in 2020 compared with 2019 (46% vs 29%, respectively), with the introduction of hypofractionated RNI in 2020 (27 of 54 cases, 50%). A smaller proportion of patients starting radiation therapy were aged >50 years in 2020, 66% (78 of 118) versus 83% (132 of 160) in 2019, P = .0027. CONCLUSIONS: A significant reduction in breast radiation therapy starts was noted during the early response to the COVID-19 pandemic, with prioritization of radiation therapy to patients associated with higher oncologic risk requiring RNI. A quick response to a health care crisis is critical and is of particular importance for higher volume cancer sites where the potential effect on resources is greater. Elsevier 2020-06-19 /pmc/articles/PMC7303606/ /pubmed/32775788 http://dx.doi.org/10.1016/j.adro.2020.06.002 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Practical considerations during COVID19 – Outcomes, education, and intervention Koch, Christine A. Lee, Grace Liu, Zhihui A. Liu, Fei-Fei Fyles, Anthony Han, Kathy Barry, Aisling Croke, Jennifer Rodin, Danielle Helou, Joelle Hahn, Ezra Isfahanian, Naghmeh DeRocchis, Jane Lofgren, Susanne Purdie, Thomas G. Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title | Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title_full | Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title_fullStr | Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title_full_unstemmed | Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title_short | Rapid Adaptation of Breast Radiation Therapy Use During the Coronavirus Disease 2019 Pandemic at a Large Academic Cancer Center in Canada |
title_sort | rapid adaptation of breast radiation therapy use during the coronavirus disease 2019 pandemic at a large academic cancer center in canada |
topic | Practical considerations during COVID19 – Outcomes, education, and intervention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303606/ https://www.ncbi.nlm.nih.gov/pubmed/32775788 http://dx.doi.org/10.1016/j.adro.2020.06.002 |
work_keys_str_mv | AT kochchristinea rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT leegrace rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT liuzhihuia rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT liufeifei rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT fylesanthony rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT hankathy rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT barryaisling rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT crokejennifer rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT rodindanielle rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT heloujoelle rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT hahnezra rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT isfahaniannaghmeh rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT derocchisjane rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT lofgrensusanne rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada AT purdiethomasg rapidadaptationofbreastradiationtherapyuseduringthecoronavirusdisease2019pandemicatalargeacademiccancercenterincanada |